-- Unveils Trial Design for Nektar Phase 2/3 Study Combining NKTR-255 with CAR-T Therapies -- -- Presents First Data for NKTR-255 in Combination with Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma -- SAN FRANCISCO, Dec. 12, 2022 /PRNewswire/ -- Nektar Therapeutics...
News Ticker
- [ March 29, 2023 ] Bioinformatics SME – Dumpa Consulting LLC – Alameda, CA San Francisco Biotech Jobs
- [ March 29, 2023 ] Technical Debt and Skills Shortages Threaten to Stifle Innovation, According to Protiviti Survey News
- [ March 29, 2023 ] Research Associate – CareDx – Brisbane, CA San Francisco Biotech Jobs
- [ March 29, 2023 ] Layoffs hit private gene therapy startups, migraine biotech Satsuma as industry squeeze doesn’t let up News
- [ March 29, 2023 ] SIMPLETHERAPY® ANNOUNCES ACQUISITION OF PHYSMETRICS AND HALCYON BEHAVIORAL News
Copyright © 2022 Biotech Networks, LLC
